Antares Pharma (FRA:MJC) Total Debt per Share : €0.14 (As of Mar. 2022)

View and export this data going back to 2006. Start your Free Trial

What is Antares Pharma Total Debt per Share?

€0.14 (As of Mar. 2022)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Antares Pharma's Total Debt Per Share for the quarter that ended in Mar. 2022 was €0.14.

Antares Pharma Total Debt per Share Historical Data

The historical data trend for Antares Pharma's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antares Pharma Total Debt per Share Chart

Antares Pharma Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Debt per Share

Get a 7-Day Free Trial

0.13

0.14

0.26

0.23

0.13

Antares Pharma Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Total Debt per Share	Get a 7-Day Free Trial															0.23	0.16	0.13	0.13	0.14

Antares Pharma Total Debt per Share Calculation

Antares Pharma's Total Debt Per Share for the fiscal year that ended in Dec. 2021 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(20.2	+	2.1)	/	170.1
	=	0.13

Antares Pharma's Total Debt Per Share for the quarter that ended in Mar. 2022 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(20.8	+	2.3)	/	170.6
	=	0.14

Antares Pharma Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Antares Pharma's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Antares Pharma (FRA:MJC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Antares Pharma Inc (FRA:MJC) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Princeton South, Suite 300, Ewing, NJ, USA, 08628

Website

https://www.antarespharma.com

Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others.

Antares Pharma (FRA:MJC) Headlines

No Headlines